NTRA

Natera Inc

$412.30

3.77 (0.92%) Today

0.26 (0.06%) After-hours

— up— down

Compare NTRA

Market Cap

$59.47B+153.2%

Revenue (TTM)

$2.71B+37.8%

Net Income (TTM)

$-195,523,944

EPS (TTM)

-1.37

Shares Out

143.22M

Open

$412.56

Previous Close

$408.79

Day Range

$407.48 – $415.75

52-Week Range

$157.43 – $415.75

Beta

1.60

Volume

1.61M

Avg Volume

1.43M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About NTRA

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.